Trial Profile
Intensive pharmacokinetics of the nelfinavir-rifabutin interaction in patients with HIV-related tuberculosis treated with a rifabutin-based regimen
Status:
Recruiting
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Efavirenz (Primary) ; Rifabutin (Primary) ; Isoniazid; Nucleoside reverse transcriptase inhibitors
- Indications HIV infections; Tuberculosis
- Focus Pharmacokinetics
- 25 Oct 2005 New trial record.